Transgenic expression of microRNA-185 causes a developmental arrest of T cells by targeting multiple genes including...

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• MicroRNA-185 (miR-185) is implicated in B cell autoantibody production and neuronal function.
• Haploinsufficiency of miR-185 is a hallmark of 22q11.2 deletion syndrome, associated with immune and neurological disorders.
• The role of miR-185 in T cell development and its molecular targets in thymocytes were previously unknown.

Purpose of the Study:

• To investigate the function of miR-185 in T cell development.
• To identify novel miR-185 targets in thymocytes.
• To elucidate the mechanism by which miR-185 deficiency impacts T cell development in 22q11.2 deletion syndrome.

Main Methods:

• Utilized a T cell transgenic approach to manipulate miR-185 levels in T cells.
• Identified miR-185 targets using molecular techniques.
• Assessed T cell development, calcium signaling, and Mzb1 levels in transgenic models and patient samples.

Main Results:

• Increased miR-185 levels attenuated T cell development at TCRβ selection and positive selection checkpoints, causing peripheral T cell lymphopenia.
• Mzb1, Nfatc3, and Camk4 were identified as novel miR-185 targets.
• Elevated miR-185 enhanced TCR-dependent intracellular calcium levels, while miR-185 knockdown diminished these responses, consistent with Mzb1 regulation.
• Mzb1 levels were elevated in thymocytes from 22q11.2 deletion syndrome patients, correlating with miR-185 haploinsufficiency.

Conclusions:

• miR-185 plays a critical role in regulating T cell development in the thymus.
• Mzb1 is a key miR-185 target involved in calcium regulation and T cell maturation.
• Dysregulation of miR-185 contributes to immune deficiencies observed in 22q11.2 deletion syndrome through impaired T cell development and altered calcium signaling.